New evidence hints that statins may protect a wider range of people with type 2 diabetes than previously assumed. A major ...

ICU statin therapy was associated with reduced 30-day mortality in patients with intracerebral haemorrhage and acute kidney injury.

"I see patients with diabetes on a regular basis, and I recommend statin therapy to everyone who is eligible," said senior author Alexander Turchin, MD, MS, of the Division of Endocrinology at Brigham ...

Lifetime use of standard statin increased QALYs by 0.24 to 0.70, with further increase seen for higher-intensity statins. HealthDay News — Statin therapy improves health outcomes and is cost-effective ...

There is decreased risk for venous thromboembolism in women aged 50 to 64 years receiving hormone therapy and statin therapy. Statin therapy is associated with a decreased risk for venous ...

Statin therapy demonstrated a dose-dependent increase in the risk for new-onset diabetes, especially among individuals already at high risk for diabetes. Higher doses of statin therapy moderately ...

Taking a statin medication is an effective, safe, and low-cost way to lower cholesterol and reduce risk of cardiovascular events. Despite clinicians recommending that many patients with diabetes take ...

Available evidence from clinical trials suggests that, compared with placebo or moderate-dose statin treatment, high-dose intensive statin therapy significantly reduces incident CV outcomes. This ...

Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...

A new pair of studies suggests that statins, drugs widely used to reduce cholesterol, may have a detrimental effect on the immune response to influenza vaccine and the vaccine's effectiveness at ...

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

Recently, a cardiologist published a commentary in Medscape arguing that physicians and scientists who challenge the putative clinical benefit of statin medications are pseudoscientists. He claimed, " ...